Balaxi Pharmaceuticals Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Get Balaxi Pharmaceuticals Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.

Balaxi Pharmaceuticals Ltd.

NSE: BALAXI

  • Market Capitalisation market-capitalisation-info ₹538 Cr
  • 12 Month Earnings monthly-earning ₹46 Cr
  • Price to Earnings price-to-earning 11.70
NSE

₹525.50

As on 02-Jun-2023 IST

up-down-arrow ₹-13.55 • -2.51%

  • Prev Close info

    ₹539.05

  • Day's Openinfo

    ₹539.05

  • Today's Highinfo

    ₹539.05

  • Today's Lowinfo

    ₹518.65

  • Today's Volumeinfo

    7,007

Stock Performance
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Balaxi Pharmaceuticals
-13.46 -1.39 -1.49 28.58 68.93 -- --
S&P BSE CDG&S
8.65 8.77 12.95 16.03 27.08 8.42 --
S&P BSE Small Cap
6.77 6.81 11.43 16.40 40.14 12.71 17.92
As on 02-Jun-2023
2022
2021
2020
Balaxi Pharmaceuticals
18.34 -19.97 725.79
S&P BSE Small Cap
-1.80 62.77 32.11
S&P BSE CDG&S
-1.31 29.72 20.33

Valuation
Stock
Peer Median

Growth & Efficiency
Stock
Peer Median

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

View Details arrow

Peer Comparison

search
search
search
search
    Comparison Details arrow

    Valuation Chart of Balaxi Pharmaceuticals Ltd.

        Financials

        View Details arrow

        Shareholding Pattern

        View Details arrow

        News & Analysis of Balaxi Pharmaceuticals Ltd.

        No Review & Analysis are available.

        All News arrow

        Incorporated

        1942

        Chairman

        --

        Managing Director

        Ashish Maheshwari

        Headquarters

        Hyderabad, Telangana

        Website

        www.balaxipharma.in
        More Details arrow
        Edit peer-selector-edit

        Key Facts

        • Market cap market-cap-information ₹537.60 Cr
        • Revenue (TTM)revenue-information ₹336.43 Cr
        • Earnings (TTM) earning-information ₹45.96 Cr
        • Cash date-information ₹28.22 Cr
        • Total Debt info ₹3.64 Cr
        • Promoters' ownership promoters_ownership 71.57%
        • Liquidity liquidity Moderate
        • 52 Week range week-range ₹303.55 - 706.00
        • Face value face-value ₹10.00
        • Shares outstanding share-outstanding 1,02,30,200
        • 10 Years Aggregate:

          CFO: ₹18.06 Cr

          EBITDA: ₹102.50 Cr

          Net Profit: ₹93.10 Cr

        About The Company

        • Incorporated 1942
        • Chairman --
        • Managing Director Ashish Maheshwari
        • Listing key-listing NSE: BALAXI
        • Country India
        • Headquarters headquarters Hyderabad, Telangana
        • Website website www.balaxipharma.in
        • Business

          Financial service activities, except insurance and pension funding
        by-stockAdd Portfolio watchlist-stock-modalAdd to watchlist Share Download Stock Report
        stock-portfolioPortfolio watchlist-stock-modalWatchlist share-fund-icon Download Stock Report
        stock-investmentPortfolio add-watchlist-iconWatchlist share-fund-plan-icon